(Q56899094)
Statements
Phase 1 dose-escalation trial of tremelimumab plus sunitinib in patients with metastatic renal cell carcinoma (English)
0 references
Phase 1 dose‐escalation trial of tremelimumab plus sunitinib in patients with metastatic renal cell carcinoma (English)
1 reference
Brian I. Rini
15 February 2011
0 references
1 reference
117
0 references
4
0 references
758-67
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference